Glenmede Trust’s Team Health Holdings Inc TMH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-149
Closed -$6K 2837
2016
Q4
$6K Sell
149
-845,251
-100% -$34.9M ﹤0.01% 2219
2016
Q3
$27.5M Buy
845,400
+2,255
+0.3% +$83.2K 0.16% 232
2016
Q2
$34.3M Buy
843,145
+170,803
+25% +$7.45M 0.21% 154
2016
Q1
$28.1M Buy
672,342
+24,093
+4% +$985K 0.18% 189
2015
Q4
$28.4M Buy
648,249
+647,649
+107,942% +$34.3M 0.19% 154
2015
Q3
$32K Buy
+600
New +$37.5K ﹤0.01% 1736
2014
Q2
Sell
-100
Closed -$4K 2421
2014
Q1
$4K Hold
100
﹤0.01% 2207
2013
Q4
$4K Hold
100
﹤0.01% 2161
2013
Q3
$3K Hold
100
﹤0.01% 2121
2013
Q2
$4K Buy
+100
New +$3.85K ﹤0.01% 2040

Other funds holding TMH

Glenmede Trust's TMH Position: Q1 2017 in Review

Glenmede Trust sold out of Team Health Holdings Inc (TMH) in Q1 2017, closing a stake of 149 shares — an estimated $6K sold.

Glenmede Trust first reported a position in TMH in Q2 2013 and held it in 10 quarters. The position peaked at $34.3M in Q2 2016. 9 funds tracked by Wall St. Rank hold TMH as of Q1 2017.

  • Glenmede Trust reported no remaining Team Health Holdings Inc position as of Q1 2017 after selling out during the quarter.
  • Glenmede Trust sold 149 Team Health Holdings Inc shares in Q1 2017, an estimated $6K.
  • Glenmede Trust first reported a position in Team Health Holdings Inc in Q2 2013 and held it in 10 quarters.
  • Glenmede Trust's Team Health Holdings Inc position peaked at $34.3M in Q2 2016.
  • 9 funds tracked by Wall St. Rank held Team Health Holdings Inc as of Q1 2017.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.